NIH-funded research R01 grant

Emergency-department tool to detect Hepatitis C

Official title: Assessing performance of a Hepatitis C Emergency Department (HepC-END) Screening Tool

Funded at University of Florida · NIH-11143909 · Data updated 2026-11-12

An AI-guided screening tool will be used in emergency departments to help find adults with undiagnosed Hepatitis C, especially people who inject drugs or have HIV.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Florida
NIH-funded
Lab location1 site (Gainesville, United States)
Project startSeptember 15, 2023
Project endJuly 31, 2028
Funding year2025
Award (this year)$664,679
NIH project number5R01DA057886-03
Project IDNIH-11143909 on NIH RePORTER

Who could benefit from this research

Could help

Adults (21+) presenting to participating emergency departments, particularly those with risk factors like injection drug use or known HIV infection, are the ideal candidates for this screening approach.

Less likely to help

Children, people not visiting participating emergency departments, and individuals already diagnosed and cured of Hepatitis C are unlikely to benefit directly from this project.

What this research studies

If you visit a participating emergency department, the project will use routine clinical information and algorithmic risk rules to flag adults who might have undiagnosed Hepatitis C. The team will develop and implement a tailored screening tool that combines electronic health record data and AI-based algorithms to identify people at higher risk. Flagged patients would be offered HCV testing in the ED, and positive results would be linked to follow-up care and antiviral treatment. The study will compare this targeted approach to existing screening methods to see if it finds more infections sustainably.

Why it matters

Potential benefit: If successful, this approach could find more people with hidden Hepatitis C earlier and connect them to curative antiviral treatment.

How similar studies have gone: Other emergency-department HCV screening programs have identified previously unrecognized infections, but using an AI-tailored screening tool in this way is a newer approach.

Where this research is happening

  • University of Florida
    Gainesville, United States
    Active

Researchers

  • Principal investigator: Park, Haesuk — University of Florida
  • Study coordinator: Park, Haesuk

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.